AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 3211167
Drug: Aminophyllin treatment
RxNorm normalized name: Aminophylline
DrugBank: Aminophylline (DB01223)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aminophyllin treatment continued for at least 6 weeks, followed by monitoring one week after discontinuation
Trial: 30422942
Drug: Parent-directed tablet
RxNorm normalized name: C.I. direct red 28 parent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parent-directed tablet computer distraction
Trial: 30422942
Drug: Parent-directed tablet
RxNorm normalized name: C.I. direct red 28 parent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parent-directed tablet computer distraction (unrestrained)
Trial: 29637918
Drug: Oral vitamin
RxNorm normalized name: vitamin A Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral vitamin D3 2000IU/day for 6 months
Trial: 28877949
Drug: Anakinra 100
RxNorm normalized name: ANAKINRA 100MG INJ,SYRINGE,1ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anakinra 100 mg subcutaneous for 5 days
Trial: 28877949
Drug: Intramuscular methylprednisolone
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular methylprednisolone 120 mg
Trial: 23645012
Drug: Thrombin solution
RxNorm normalized name: thrombin
DrugBank: Thrombin (DB11300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombin solution (n=10)
Trial: 19398604
Drug: Clopidogrel (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel (300 mg on the first day and then 75 mg once daily for 3 consecutive days)
Trial: 7955806
Drug: Prazosin (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prazosin (0.25 to 1.0 mg)
Trial: 2701751
Drug: Sodium salt
RxNorm normalized name: Hepes Sodium Salt
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium salt of L‐thyroxine (L‐T4)
Trial: 29147070
Drug: Psychobiotics oral
RxNorm normalized name: ambutonium and psycholeptics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychobiotics oral suspension group (POSG)
Trial: 29147070
Drug: Dietary treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary treatment group (DTG)
Trial: 26305617
Drug: TZD discontinuation
RxNorm normalized name: guaifenesin / hydrocodone bitartrate / phenylephrine hydrochloride Oral Solution [Entex HC Discontinued]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TZD discontinuation for 1-2 years
Trial: 26305617
Drug: TZD discontinuation
RxNorm normalized name: guaifenesin / hydrocodone bitartrate / phenylephrine hydrochloride Oral Solution [Entex HC Discontinued]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TZD discontinuation for >2 years
Trial: 26305617
Drug: TZD use
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TZD use and discontinuation
Trial: 21699951
Drug: 9 μg
RxNorm normalized name: aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 9 μg HA/strain TIV ID
Trial: 21699951
Drug: 6 μg
RxNorm normalized name: aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 6 μg HA/strain TIV ID
Trial: 21699951
Drug: 3 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 μg HA/strain TIV ID
Trial: 21699951
Drug: 6 μg
RxNorm normalized name: aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 6 μg HA/strain TIV ID (50-64 years subgroup)
Trial: 21699951
Drug: Standard 15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard 15 μg HA/strain TIV IM
Trial: 21699951
Drug: ID administration
RxNorm normalized name: Fluid Administration Set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ID administration
Trial: 21699951
Drug: TIV ID
RxNorm normalized name: influenza A virus (H1N1) antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TIV ID administration experience
Trial: 18298480
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of BNP and pneumonia severity index (PSI)
Trial: 8829417
Drug: Lidocaine 70
RxNorm normalized name: lidocaine 70 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine 70 mg in 7.5% glucose
Trial: 8829417
Drug: Meperidine 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meperidine 60 mg in saline
Trial: 1640755
Drug: Random CO2
RxNorm normalized name: jojoba oil, randomized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Random CO2 inhalation
Trial: 1640755
Drug: Simultaneous CO2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simultaneous CO2 inhalation and exercise
Trial: 6340511
Drug: Single MCA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single MCA injection
Trial: 6340511
Drug: Single MCA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single MCA injection after uterine lavage
Trial: 6340511
Drug: Two MCA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two MCA injections 1 month apart
Trial: 26091383
Drug: Subantimicrobial, modified-release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subantimicrobial, modified-release (MR) Doxycycline 40 mg
Trial: 19531281
Drug: Cerebrolysin (Cere)
DrugBank: Cerebrolysin (DB16599)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cerebrolysin (Cere) 10, 30 or 60 ml for 12 weeks
Trial: 19531281
Drug: Cerebrolysin (Cere)
DrugBank: Cerebrolysin (DB16599)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cerebrolysin (Cere) 60 ml
Trial: 15390050
Drug: Ropinirole (0.25-4.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropinirole (0.25-4.0 mg/day)
Trial: 8058422
Drug: Acetazolamide (ACTZ;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetazolamide (ACTZ; 5 mg/kg/dose Q6h for 36 hr)
Trial: 8058422
Drug: Aminophylline (AMINO;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aminophylline (AMINO; 8 mg/kg bolus then 2.5 mg/kg Q12h for 36 hr)
Trial: 27999118
Drug: Oral Contraceptives
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral Contraceptives (OCs) induced menses
Trial: 26711755
Drug: Daptomycin 8
RxNorm normalized name: Daptomycin
DrugBank: Daptomycin (DB00080)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Daptomycin 8 mg/kg/day
Trial: 26711755
Drug: Daptomycin 10
RxNorm normalized name: daptomycin 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daptomycin 10 mg/kg/day
Trial: 26711755
Drug: Daptomycin 6
RxNorm normalized name: Daptomycin
DrugBank: Daptomycin (DB00080)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Daptomycin 6 mg/kg/day to 10 mg/kg/day
Trial: 22164808
Drug: Equine-assisted activities
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Equine-assisted activities (therapeutic riding treatment)
Trial: 16710114
Drug: 16.5 mg
RxNorm normalized name: thymol 16.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 16.5 mg D9‐tétrahydrocannabinol (THC)
Trial: 16710114
Drug: 45.7 mg
RxNorm normalized name: menthol 45.7 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 45.7 mg THC as a cannabis milk decoction
Trial: 12705062
Drug: Rofecoxib (12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rofecoxib (12.5 mg daily)
Trial: 12705062
Drug: Meloxicam (7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meloxicam (7.5 mg daily)
Trial: 12705062
Drug: Gastro-protective agents
RxNorm normalized name: PROTECTIVE AGENTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gastro-protective agents (proton pump inhibitors or misoprostol)
Trial: 9082601
Drug: Isosorbide dinitrate
RxNorm normalized name: Isosorbide Dinitrate
DrugBank: Isosorbide dinitrate (DB00883)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide dinitrate (10-30 mg 4 times a day)
Trial: 1431010
Drug: Paroxetine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine (20 mg daily, increased to 30 mg after 1 week)
Trial: 1431010
Drug: Amitriptyline (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline (50 mg daily, increased to 100 mg after 1 week)
Trial: 3904312
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg bromocriptine per os
Trial: 31395229
Drug: Intra-umbilical vein
RxNorm normalized name: Sus scrofa vein preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-umbilical vein injection of carbetocin (1 mL containing 100 μg carbetocin diluted in 20 mL normal saline 0.9%)
Trial: 31395229
Drug: Intra-umbilical vein
RxNorm normalized name: Sus scrofa vein preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-umbilical vein injection of oxytocin (20 IU diluted in 20 mL normal saline 0.9%)
Trial: 28895655
Drug: Insulin glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin glargine (titrated doses targeting fasting normoglycaemia)
Trial: 24910271
Drug: Deep bolus
RxNorm normalized name: Deep Sea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deep bolus injection into the mid‐ to lateral cheek
Trial: 24910271
Drug: Local mid‐
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local mid‐ to deep dermal injection into the nasolabial fold
Trial: 24910271
Drug: Both deep
RxNorm normalized name: Deep Sea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both deep injection into the mid‐ to lateral cheek and local mid‐ to deep dermal injection into the nasolabial fold
Trial: 22399125
Drug: Bupivacaine combined
RxNorm normalized name: bupivacaine, combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine combined with low dose fentanyl (Group B)
Trial: 22399125
Drug: Levobupivacaine combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levobupivacaine combined with low dose fentanyl (Group L)
Trial: 18184902
Drug: Soy protein
RxNorm normalized name: Soy Protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy protein diet (0.8 g protein/kg body weight; 35% animal proteins, 35% textured soy protein, 30% vegetable proteins)
Trial: 7586939
Drug: Lys(B28), Pro(B29)-human
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lys(B28), Pro(B29)-human insulin (lispro)
Trial: 2179176
Drug: Sucralfate (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sucralfate (1 g suspension, 4 times a day orally)
Trial: 2179176
Drug: Standard oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard oral hygiene (control group)
Trial: 23984182
Drug: EFT treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EFT treatment
Trial: 9433422
Drug: BNP concentration
RxNorm normalized name: BNP
DrugBank: Nesiritide (DB04899)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: BNP concentration of 17.9 pg/mL or more
Trial: 8017305
Drug: Cardiac catheterization
RxNorm normalized name: Leonurus cardiaca extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cardiac catheterization with heparin
Trial: 8017305
Drug: Peripheral angiography
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peripheral angiography without heparin
Trial: 2598979
Drug: Glucagon with
RxNorm normalized name: Glucagon
DrugBank: Glucagon (DB00040)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Glucagon with surfactants (9-lauryl ether as spray, sodium glycocholate as spray or powder)
Trial: 2598979
Drug: Human calcitonin
RxNorm normalized name: human calcitonin
DrugBank: Human calcitonin (DB06773)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Human calcitonin with surfactants (dihydrofusinate as spray or powder, glycocholate as spray)
Trial: 2598979
Drug: Powders and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Powders and spray solutions of glucagon and calcitonin
Trial: 7013055
Drug: sulindac 100
RxNorm normalized name: sulindac 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sulindac 100 mg b.i.d. (plus indomethacin placebo)
Trial: 7013055
Drug: indomethacin 25
RxNorm normalized name: indomethacin 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: indomethacin 25 mg t.i.d. (plus sulindac placebo)
Trial: 26871805
Drug: Intravenous low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous low-dose ketamine 0.5 mg/kg (group K)
Trial: 20204984
Drug: Standard care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard care plus psychological preparation
Trial: 17586452
Drug: Meglumine antimoniate
RxNorm normalized name: meglumine antimoniate
DrugBank: Meglumine antimoniate (DB13732)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meglumine antimoniate (20mgSb(5)/kg body weight daily for 14 days)
Trial: 15637501
Drug: Ginger (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginger (various forms, dosage not specified)
Trial: 9790462
Drug: Dilatation plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dilatation plus Nd‐YAG laser therapy
Trial: 9363233
Drug: Vaginal capsules
RxNorm normalized name: Vaginal Insert
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal capsules containing seminal plasma
Trial: 30955461
Drug: Treatment of
RxNorm normalized name: DRUGS FOR TREATMENT OF LEPRA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment of delirium
Trial: 21325466
Drug: Drospirenone/ethinyl estradiol
RxNorm normalized name: DROSPIRENONE/ETHINYL ESTRADIOL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drospirenone/ethinyl estradiol (3 mg/30 μg)
Trial: 19802544
Drug: Calcium dobesilate
RxNorm normalized name: CALCIUM DOBESILATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium dobesilate capsule
Trial: 16763247
Drug: Oral amoxicillin
RxNorm normalized name: amoxicillin Oral Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral amoxicillin (3 times daily for 5 days)
Trial: 16763247
Drug: Placebo (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (3 times daily for 5 days)
Trial: 15642961
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose of Artemotil (4.8 mg/kg on day 0 at 0 hours, 1.6 mg/kg at 6 hours, and 1.6 mg/kg/day on days 1-4)
Trial: 15642961
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose of Artemotil (3.2 mg/kg on day 0 and 1.6 mg/kg/day on days 1-4)
Trial: 15642961
Drug: Patient 151
RxNorm normalized name: etranacogene dezaparvovec
DrugBank: Etranacogene dezaparvovec (DB16791)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient 151 (high dose regimen)
Trial: 31657712
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg furosemide
Trial: 25840035
Drug: Standard care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard care plus daily tailored text messages for 6 months
Trial: 23359039
Drug: Dual-hormone closed-loop
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual-hormone closed-loop delivery
Trial: 23359039
Drug: Standard insulin-pump
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard insulin-pump therapy (control)
Trial: 18056753
Drug: Conventional physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional physical therapy intervention (comparison group)
Trial: 14668186
Drug: N-acetylcysteine (NAC)
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (NAC) in a 0.04 mol/l solution in Plegisol
Trial: 8648016
Drug: Albuterol sulfate
RxNorm normalized name: Albuterol Sulfate
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol sulfate (4 mg twice daily)
Trial: 6643332
Drug: Amikacin 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amikacin 7.5 mg/kg by iv infusion
Trial: 6643332
Drug: Gentamicin 1.5
RxNorm normalized name: HYDROCORTISONE ACEPONATE 1.11 mg in 1 mL / MICONAZOLE NITRATE 17.4 mg in 1 mL / GENTAMICIN 1.5 mg in 1 mL AURICULAR (OTIC) SUSPENSION [EASOTIC]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gentamicin 1.5 mg/kg
Trial: 6643332
Drug: Tobramycin 1
RxNorm normalized name: tobramycin 1 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tobramycin 1 mg/kg
Trial: 31697304
Drug: Bevacizumab 0.625
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bevacizumab 0.625 mg
Trial: 31697304
Drug: Bevacizumab 0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bevacizumab 0.25 mg, 0.125 mg, 0.063 mg, or 0.031 mg
Trial: 28118231
Drug: Dexamethasone 5
RxNorm normalized name: dexamethasone 5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 5 mg (control group)
Trial: 28118231
Drug: Dexamethasone 15
RxNorm normalized name: MENTHOL 200 mg in 20000 mg / CAMPHOR (SYNTHETIC) 200 mg in 20000 mg / DEXAMETHASONE 15 mg in 20000 mg TOPICAL OINTMENT [999 ITCH RELIEF]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 15 mg (study group)
Trial: 28118231
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (5 mg and 15 mg)
Trial: 24290111
Drug: Oral cholecalciferol
RxNorm normalized name: cholecalciferol Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral cholecalciferol (vitamin D3) 5000 IU/d for 28 days
Trial: 15452302
Drug: Oral prednisone
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral prednisone (1250 mg)
Trial: 8315423
Drug: Doxorubicin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxorubicin (500 mg/m2)
Trial: 8315423
Drug: Mitoxantrone (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mitoxantrone (120 mg/m2)
Trial: 3575355
Drug: Phenylpropanolamine (PPA)
DrugBank: Phenylpropanolamine (DB00397)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Phenylpropanolamine (PPA) 37.5 mg
Trial: 18840372
Drug: Test formulation
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test formulation of 30 mg sublingual ketorolac
Trial: 18840372
Drug: Reference formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference formulation of 30 mg sublingual ketorolac
Trial: 10563527
Drug: Natural interferon-alphaN3
RxNorm normalized name: interferon beta natural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Natural interferon-alphaN3 with N-acetyl cysteine 1200 mg/day and vitamin E 600 mg/day
Trial: 27382136
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of television segments and vinyl banners
Trial: 23230666
Drug: Micro-invasive surgical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micro-invasive surgical therapy (endoscope-assisted posterior operation)
Trial: 23230666
Drug: Traditional surgical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional surgical therapy (control group)
Trial: 18758677
Drug: Acupuncture together
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acupuncture together with tricyclic antidepressants and exercise (n=34)
Trial: 18758677
Drug: Tricyclic antidepressants
RxNorm normalized name: TRICYCLIC ANTIDEPRESSANTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tricyclic antidepressants and exercise only (n=24)
Trial: 6723694
Drug: Slow-release mexiletine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slow-release mexiletine 360 mg 12 hourly
Trial: 6723694
Drug: Conventional mexiletine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional mexiletine 200 mg 8 hourly
Trial: 30672623
Drug: Secukinumab 300
RxNorm normalized name: secukinumab 300 MG in 2 ML Auto-Injector
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Secukinumab 300 mg fixed interval (FI)
Trial: 30672623
Drug: Secukinumab 150
RxNorm normalized name: secukinumab 150 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Secukinumab 150 mg fixed interval (FI)
Trial: 29857882
Drug: Herbal acupoint
RxNorm normalized name: Hyperici herba
DrugBank: St. John's Wort (DB01323)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Herbal acupoint therapy (HAT)
Trial: 20195673
Drug: Cefepime (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefepime (2 g/12 h) plus amikacin (15 mg/kg/day)
Trial: 20195673
Drug: Piperacillin/tazobactam (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piperacillin/tazobactam (4 g/500 mg/8 h) plus amikacin
Trial: 15662091
Drug: Fluvastatin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin (40 mg/d)
Trial: 11883790
Drug: L-arginine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine infusion (30 g/300 ml/30 min)
Trial: 2287792
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate 16 mg orally
Trial: 2287792
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate 4 mg intranasally for 1 week
Trial: 2287792
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate 1 mg or 16 mg
Trial: 27261986
Drug: Focused meditation
RxNorm normalized name: benzalkonium chloride Topical Foam [Meditize]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Focused meditation (8-week program with weekly 75 min classes)
Trial: 20586923
Drug: Abciximab bolus
RxNorm normalized name: Abciximab
DrugBank: Abciximab (DB00054)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Abciximab bolus followed by a 12-h placebo infusion and concomitant 600-mg clopidogrel
Trial: 20586923
Drug: Abciximab bolus
RxNorm normalized name: Abciximab
DrugBank: Abciximab (DB00054)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Abciximab bolus + a 12-h infusion and 300 mg of clopidogrel